logo
Plus   Neg
Share
Email

Check Point Software Q1 Results Top View - Quick Facts

Cyber security solutions provider Check Point Software Technologies Ltd. (CHKP) reported Monday that its net income for the first quarter was $178.7 million or $1.23 per share, compared to $179.9 million or $1.15 per share in the prior-year quarter.

Excluding items, adjusted net income for the quarter was $205.9 million or $1.42 per share, compared to $205.5 million or $1.32 per share in the year-ago quarter.

On average, 30 analysts polled by Thomson Reuters expected the company to report earnings of $1.38 per share for the quarter. Analysts' estimates typically exclude special items.

Total revenue for the quarter increased 3 percent to $486.5 million from $471.8 million in the same quarter last year. Analysts expected revenues of $480.35 million.

As of March 31, 2020, deferred revenues were $1.35 billion, up 3 percent from last year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Avalon Furniture is recalling about 9,500 units of Cottage Town Bedroom Furniture collection sold through Rooms To Go due to violation of federal lead paint ban, the U.S. Consumer Product Safety Commission said in a statement. According to the agency, the base coat paint used on pieces within the furniture collection contains levels of lead that exceed the federal lead paint standard. Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Phase 3 trial of arthritis drug Kevzara (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints. In the trial, Kevzara was added to best supportive care compared to best supportive care alone (placebo). The companies have stopped the U.S. trial. Shares of Moderna Inc. (MRNA) slipped over 5% on Thursday after a report claimed that the biotechnology company's late-stage trial for a coronavirus vaccine will be delayed. Moderna is developing mRNA-1273 in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID). The...
Follow RTT